Planet Labs Other Income (Expense) decreased by 184.6% to -$114.01M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 676.0%, from -$14.69M to -$114.01M. Over 3 years (FY 2023 to FY 2026), Other Income (Expense) shows a downward trend with a 116.2% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$10.73M | $4.07M | -$12.84M | $3.67M | $3.27M | $2.84M | $4.79M | $10.56M | $5.89M | $10.21M | $3.40M | $5.72M | $1.81M | $2.55M | -$14.69M | $11.07M | -$4.14M | -$40.06M | -$114.01M |
| QoQ Change | — | +138.0% | -415.1% | +128.6% | -11.0% | -13.2% | +68.9% | +120.4% | -44.2% | +73.4% | -66.7% | +68.1% | -68.4% | +41.3% | -675.7% | +175.4% | -137.3% | -868.8% | -184.6% |
| YoY Change | — | — | — | +134.2% | -19.9% | +122.1% | — | +187.8% | +80.3% | +260.1% | -28.9% | -45.8% | -69.3% | -75.0% | -531.7% | +93.5% | -329.0% | <-999% | -676.0% |